Mineralys Therapeutics Inc MLYS Valuation Ratios and Share Stats

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics Inc (MLYS) Financials

Mineralys Therapeutics Inc (MLYS)

12.70

0.21

(1.68%)

Closed November 25 4:00PM

Delayed by 15 minutes

12.70

0.00

(0.00%)

After Hours: 5:30PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-461.104	-307.795	-47.463	-39.28
Return on Equity (%)	190.492	146.354	79.259	-76.129
Return on Invested Capital (%)	162.732	-1527.948	-56.815	-49.31
Operating Margin (%)	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A
Book Value Per Share	-0.062	0.103	0.464	5.867
Earnings Per Share	-0.059	-0.33	-0.13	-1.749
Cash Per Share	0.024	0.181	0.383	1.199
Working Capital Per Share	-0.062	0.103	0.457	5.805
Operating Profit Per Share	N/A	N/A	N/A	N/A
EBIT Per Share	-0.059	-0.33	-0.13	-1.749
EBITDA Per Share	-0.059	-0.33	-0.13	-1.749
Free Cash Flow Per Share	-0.059	-0.33	-0.13	-1.749

Liquidity Ratios

Year End December 30 2023	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A
Shares Outstanding	58.44M	58.76M	6.42M	N/A

Key Stats and Ratios

Year End December 30 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	6.42M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	621.61M
Price to Earnings Ratio	-8.79
Price to Sales Ratio	0
Price to Cash Ratio	12.82
Price to Book Ratio	2.62
Dividend Yield	-

Share Statistics

Shares Outstanding	49.77M
Average Volume (1 week)	192.73k
Average Volume (1 Month)	254.41k
52 Week Change	106.50%
52 Week High	16.905
52 Week Low	5.85

More Ratios Coming Soon!

Mineralys Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions